Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Peter J. Feilen"'
Autor:
Leonie Lang, Weiwei Zhang, Christina Jäger, M Alt, Peter J. Feilen, Günter Päth, Chune Liu, Nikolaos Perakakis, Jochen Seufert, Katharina Laubner, J Straetener, Natia Peradze
Publikováno v:
Molecular and cellular endocrinology. 473
Mesenchymal stem cells (MSC) are of interest for cell therapy since their secreted factors mediate immunomodulation and support tissue regeneration. This study investigated the direct humoral interactions between MSC and pancreatic β-cells using hum
Autor:
Marcus Behringer, Peter J. Feilen, M Weber, M. Salinas Jungjohann, Ernst Bamberg, Julio A. Vásquez, Matthias M. Weber, A. Steinbach, Heiko Zimmermann, L. Pließ, Dirk Zimmermann, Ulrich Zimmermann, Friederike Ehrhart, J. Spitz, Stephan Schneider, A. Katsen, P. Geßner, R. Wolf
Publikováno v:
Biomaterials. 26:6386-6393
Alginate-based microencapsulation is a promising method for long-term maintenance of cellular and membrane function of the cells and tissue fragments required for in vitro and in vivo biosensors, for tissue engineering and particularly for immunoisol
Autor:
Randolph Reuss, P. Geßner, Frank Volke, Heiko Zimmermann, Ulrich Zimmermann, Stephan Schneider, Friederike Ehrhart, A. Steinbach, Julio A. Vásquez, Bertram Manz, M Weber, Matthias M. Weber, F.R. Ihmig, Marcus Behringer, R. Wolf, Vladimir L. Sukhorukov, A. Katsen, Dirk Zimmermann, L.H. Wegner, Peter J. Feilen
Publikováno v:
Journal of Materials Science: Materials in Medicine. 16:491-501
The concept of encapsulated-cell therapy is very appealing, but in practice a great deal of technology and know-how is needed for the production of long-term functional transplants. Alginate is one of the most promising biomaterials for immunoisolati
Autor:
C. Schwanstecher, Oliver Thews, S. Comagic, C-Y. Shiue, Markus Piel, Peter J. Feilen, B Wängler, M. Schwanstecher, Stephan Schneider, Frank Rösch, A. Alavi, Ralf Schirrmacher, Esther Schirrmacher, S. Höhnemann
Publikováno v:
Nuclear Medicine and Biology. 31:639-647
18F-labeled non-sulfonylurea hypoglycemic agent (S)-2-(2-[(18)F]fluoroethoxy)-4-((3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl)-benzoic acid ([(18)F]repaglinide), a derivative of the sulfonylurea-receptor (SUR) ligand repaglinide, was
Autor:
Peter J. Feilen, Abass Alavi, Peter H. Kann, Alexander Schmitz, Stefan Schneider, Ralf Schirrmacher, Chyng-Yann Shiue, Marc Weber, Frank Rösch
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 45:763-774
Summary Tolbutamide (1) is a sulfonurea agent used to stimulate insulin secretion in type 2 diabetic patients. Its analogue 1-(4-(2-[ 18 F]fluoroethoxy)benzenesulfonyl)-3butyl urea (3) was synthesized in overall radiochemical yields of 45% as a poten
Autor:
Stephan Schneider, Rainer Pommersheim, Jürgen Beyer, Peter J. Feilen, Simon Preuss, Svend Berger, Viola Slotty, Daniel Kampfner
Publikováno v:
Biomaterials. 22:1961-1970
In 1980, Lim and Sun introduced a microcapsule coated with an alginate/polylysine complex for encapsulation of pancreatic islets. Characteristic to this type of capsule is, that it consists of a plain membrane which is formed during a single procedur
Autor:
Esther Mettler, Heiko Zimmermann, Christian Fottner, Matthias M. Weber, Peter J. Feilen, Laura M. Schreiber, Friederike Ehrhart, Frederik Wiegand, Dong Yun Lee, Stefan Fischer, Yong Hwa Hwang, Anja Trenkler
Publikováno v:
Xenotransplantation. 20(4)
Islet cell transplantation is a promising option for the restoration of normal glucose homeostasis in patients with type 1 diabetes. Because graft volume is a crucial issue in islet transplantations for patients with diabetes, we evaluated a new meth
Autor:
S. J. Shiue, Ralf Schirrmacher, Peter J. Feilen, Stephan Schneider, A. Alavi, Frank Rösch, Grace G. Shiue, Jürgen Beyer
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 44:S418-S420
The syntheses and first in vitro evaluations for two fluoride bearing sulfonylurea derivatives are reported. Firstly, the tolbutamide derivative 1-[4-(2-[18F]fluoroethoxy)benzenesulfonyl]-3-butyl urea (2-[18F]fluoroethyl-tolbutamide) could be labeled
Autor:
P. Gessner, Alisa Katsen-Globa, Heiko Zimmermann, Ulrich Zimmermann, J. Metze, Peter J. Feilen, Stephen G. Shirley, Kilian J. Müller, Dirk Zimmermann, M Weber, Marcus Behringer, Gertraud Zimmermann, Friederike Ehrhart
Replacing dysfunctional endocrine cells or tissues (e.g. islets, parathyroid tissue) by functional, foreign material without using immunosuppressives could soon become reality. Immunological reactions are avoided by encapsulating cells/tissues in hyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee83a67f50c08267c241d35b8dc1de11
https://publica.fraunhofer.de/handle/publica/215034
https://publica.fraunhofer.de/handle/publica/215034
Autor:
Peter J. Feilen, Christian Fottner, M. Goetz, Matthias M. Weber, MF Neurath, Peter Bartenstein, Ralf Kiesslich, Esther Schirrmacher, Peter R. Galle
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 114